newsfilter
← Latest News
GlobeNewswire·

Indivior PLC to Acquire Opiant Pharmaceuticals

Indivior to acquire Opiant Pharmaceuticals for total consideration of $28.00 per share comprising of an upfront cash payment of $20.00 per share at closing plus contingent value rights (CVRs) worth up to $8.00 per share